Aclaris Therapeutics, Inc. Stock Issued During Period, Shares, Restricted Stock Award, Gross
Aclaris Therapeutics, Inc. (ACRS) reported Stock Issued During Period, Shares, Restricted Stock Award, Gross of 2.73 million shares for the 1-month period ending 2012-07-31, per its 10-K filed 2018-03-12.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross · last filed 2018-03-12
- 2012-07-31: Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month 2.73M shares; Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month as first filed 1.92M shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month | Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month as first filed |
|---|---|---|
| 2012-07-31 | 2.73M shares 10-K · filed 2018-03-12 | 1.92M shares 10-Q · filed 2015-12-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |